Search

everythinglearnresearchcommunity

for

Search:↓

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Women with PCOS have more emotional and body image issues than healthy women.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Lower melatonin levels are linked to more skin aging.

Hair loss can be an early sign of HIV infection.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Neurohormones help control skin health and could treat skin disorders.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.